A critical appraisal of vasomotor symptom assessment tools used in clinical trials evaluating hormone therapy compared to placebo
Conclusion:
Although oral hormone therapy improves VMS scores, there is a paucity of evidence on whether it improves HRQOL in menopausal women. Future studies using validated, patient-reported outcome measures that directly assess HRQOL are needed.
Source: Menopause - Category: OBGYN Tags: Review Articles Source Type: research
More News: Clinical Trials | Hormonal Therapy | Hormones | Men | Menopause | OBGYN | Study | USA Health | Women